Last updated: 2026-10-15 21:34:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $60.57, with a market capitalization of $115.76B and a P/E ratio of 13.05. Over the past 52 weeks, its price has ranged from $42.52 to $68.64. This page covers its latest market performance, valuation, price trends and company information.
$115.76B | |
$60.88 | |
$81.44 | |
$16.00 | |
$59.28 | |
2.29M | |
11.53M | |
13.05 | |
$68.64 | |
$42.52 | |
4.21% | |
2001-12-30 |
Bristol-Myers Squibb Co. (BMY) is trading at $60.76 in after-hours trading as of 2026-10-15 21:29:00, up 2.49% ($1.48) from the regular-session close of $59.28.
After-hours trading shows how investors are pricing BMY after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $59.59 to $60.57, representing a gain of 1.65% ($0.98).
The stock traded between $56.15 and $61.00 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.
The average daily volume was 13.84 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 69.1%
BMY is currently trading at $60.57, placing it 69.1% of the way from its 52-week low of $42.52 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32500 |
| CEO | Christopher S. Boerner |
| Founded | 1887 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.